Home /Biblio

Biblio

Found 401 results
Author Keyword Title Type [ Year(Asc)]
2020
F. Falcone, Maggiore, U. Leone Robe, Di Donato, V., Perrone, A. Myriam, Frigerio, L., Bifulco, G., Polterauer, S., Casadio, P., Cormio, G., Masciullo, V., Malzoni, M., and Greggi, S., “Fertility-sparing treatment for intramucous, moderately differentiated, endometrioid endometrial cancer: a Gynecologic Cancer Inter-Group (GCIG) study”, Journal of Gynecologic Oncology, vol. 31, 2020.
2019
F. Heitz, Harter, P., Åvall-Lundqvist, E., Reuss, A., Pautier, P., Cormio, G., Colombo, N., Reinthaller, A., Vergote, I., Poveda, A., Ottevanger, P. B., Hanker, L. C., Leminen, A., Alexandre, J., Canzler, U., Sehouli, J., Herrstedt, J., Fiane, B., Merger, M., and A Bois, du, “Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12.”, Gynecol Oncol, vol. 152, no. 2, pp. 235-242, 2019.
I. Ray‐Coquard, Cibula, D., Mirza, M. R., Reuss, A., Ricci, C., Colombo, N., Koch, H., Goffin, F., González‐Martin, A., Ottevanger, P. B., Baumann, K., Bjørge, L., Lesoin, A., Burges, A., Rosenberg, P., Gropp‐Meier, M., Harrela, M., Harter, P., Frenel, J. ‐S., Minarik, T., Pisano, C., Hasenburg, A., Merger, M., and Bois, A., “Final results from GCIG/ENGOT/AGO‐OVAR 12, a randomised placebo‐controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer”, International Journal of Cancer, vol. 146, no. 2, pp. 439 - 448, 2019.
G. F. Vercellino, Erdemoglu, E., Lichtenberg, P., Muallem, M. Z., Richter, R., Abu-Rustum, N. R., Plante, M., Lécuru, F., Greggi, S., Monk, B. J., Sagae, S., Denkert, C., Keller, M., Alhakeem, M., Hellriegel, M., Dückelmann, A. M., Chiantera, V., and Sehouli, J., “A GCIG international survey: clinical practice patterns of sentinel lymph node biopsies in cervical cancer.”, Arch Gynecol Obstet, 2019.
M. Bagnoli, Shi, T. Yan, Gourley, C., Speiser, P., Reuss, A., Nijman, H. W., Creutzberg, C. L., Scholl, S., Negrouk, A., Brady, M. F., Hasegawa, K., Oda, K., McNeish, I. A., Kohn, E. C., Oza, A. M., MacKay, H., Millan, D., Bennett, K., Scott, C., and Mezzanzanica, D., “Gynecological Cancers Translational, Research Implementation, and Harmonization: Gynecologic Cancer InterGroup Consensus and Still Open Questions.”, Cells, vol. 8, no. 3, 2019.
I. Ray-Coquard, Pautier, P., Pignata, S., Pérol, D., González-Martín, A., Berger, R., Fujiwara, K., Vergote, I., Colombo, N., Maenpaa, J., Selle, F., Sehouli, J., Lorusso, D., Alía, E. M. Guerra, Reinthaller, A., Nagao, S., Lefeuvre-Plesse, C., Canzler, U., Scambia, G., Lortholary, A., Marmé, F., Combe, P., de Gregorio, N., Rodrigues, M., Buderath, P., Dubot, C., Burges, A., You, B., Pujade-Lauraine, E., and Harter, P., “Olaparib plus Bevacizumab as First-Line Maintenance in Ovarian Cancer”, New England Journal of Medicine, vol. 381, no. 25, pp. 2416 - 2428, 2019.
I. Vergote, A. Bois, du, Floquet, A., Rau, J., Kim, J. - W., del Campo, J. M., Friedlander, M., Pignata, S., Fujiwara, K., Colombo, N., Mirza, M. R., Monk, B. J., Tsibulak, I., Calvert, P. M., Herzog, T. J., Hanker, L. C., Meunier, J., Lee, J. - Y., Bologna, A., Carrasco-Alfonso, M. J., and Harter, P., “Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer”, Gynecologic Oncology, vol. 155, no. 2, pp. 186 - 191, 2019.
P. Harter, Sehouli, J., Lorusso, D., Reuss, A., Vergote, I., Marth, C., Kim, J. - W., Raspagliesi, F., Lampe, B., Aletti, G., Meier, W., Cibula, D., Mustea, A., Mahner, S., Runnebaum, I. B., Schmalfeldt, B., Burges, A., Kimmig, R., Scambia, G., Greggi, S., Hilpert, F., Hasenburg, A., Hillemanns, P., Giorda, G., von Leffern, I., Schade-Brittinger, C., Wagner, U., and Bois, Adu, “A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms.”, N Engl J Med, vol. 380, no. 9, pp. 822-832, 2019.
F. R. Lecuru, McCormack, M., Hillemanns, P., Anota, A., Leitao, M., Mathevet, P., Zweemer, R., Fujiwara, K., Zanagnolo, V., Eriksson, A. Gerda Zahl, Hudson, E., Ferron, G., and Plante, M., “SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study”, International Journal of Gynecologic Cancer, vol. 29, no. 4, pp. 829 - 834, 2019.
A. Reuss, Bois, Adu, Harter, P., Fotopoulou, C., Sehouli, J., Aletti, G., Guyon, F., Greggi, S., Mosgaard, B. Jul, Reinthaller, A., Hilpert, F., Schade-Brittinger, C., Chi, D. S., and Mahner, S., “TRUST: Trial of Radical Upfront Surgical Therapy in advanced ovarian cancer (ENGOT ov33/AGO‐OVAR OP7)”, International Journal of Gynecologic Cancer, vol. 29, no. 8, pp. 1327 - 1331, 2019.
2018
S. M. de Boer, Powell, M. E., Mileshkin, L. R., Katsaros, D., Bessette, P., Haie-Meder, C., Ottevanger, P. B., Ledermann, J. A., Khaw, P., Colombo, A., Fyles, A., Baron, M. - H., Jürgenliemk-Schulz, I. M., Kitchener, H. C., Nijman, H. W., Wilson, G., Brooks, S., Carinelli, S., Provencher, D. M., Hanzen, C., Lutgens, L. C. H. W., Smit, V. T. H. B. M., Singh, N., Do, V., D'Amico, R., Nout, R. A., Feeney, A., Verhoeven-Adema, K. W., Putter, H., and Creutzberg, C. L., “Adjuvant chemoradiotherapy versus radiotherapy alone for women with high-risk endometrial cancer (PORTEC-3): final results of an international, open-label, multicentre, randomised, phase 3 trial.”, Lancet Oncol, 2018.
S. C. Dowdy and Glaser, G. E., “Adjuvant therapy for women with high-risk endometrial carcinoma.”, Lancet Oncol, 2018.
B. J. Ager, Gallardo-Rincon, D., de León, D. Cantú, Chávez-Blanco, A., Chuang, L., Dueñas-González, A., Gomez-Garcia, E., Jerez, R., Jhingran, A., McCormack, M., Mileshkin, L., Pérez-Plasencia, C., Plante, M., Poveda, A., and Gaffney, D. K., “Advancing clinical research globally: Cervical cancer research network from Mexico.”, Gynecol Oncol Rep, vol. 25, pp. 90-93, 2018.
V. D. Gonzalez, Samusik, N., Chen, T. J., Savig, E. S., Aghaeepour, N., Quigley, D. A., Huang, Y. - W., Giangarrà, V., Borowsky, A. D., Hubbard, N. E., Chen, S. - Y., Han, G., Ashworth, A., Kipps, T. J., Berek, J. S., Nolan, G. P., and Fantl, W. J., “Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry.”, Cell Rep, vol. 22, no. 7, pp. 1875-1888, 2018.
P. T. Ramirez, Frumovitz, M., Pareja, R., Lopez, A., Vieira, M., Ribeiro, R., Buda, A., Yan, X., Shuzhong, Y., Chetty, N., Isla, D., Tamura, M., Zhu, T., Robledo, K. P., Gebski, V., Asher, R., Behan, V., Nicklin, J. L., Coleman, R. L., and Obermair, A., “Minimally Invasive versus Abdominal Radical Hysterectomy for Cervical Cancer.”, N Engl J Med, vol. 379, no. 20, pp. 1895-1904, 2018.
M. Leonard Friedlander, Rau, J., Lee, C. Khoon, Meier, W., Lesoin, A., Kim, J. - W., Poveda, A. M., Buck, M., Scambia, G., Shimada, M., Hilpert, F., King, M. Trudy, Debruyne, P., Bologna, A., Malander, S., Monk, B. J., Petru, E., Calvert, P., Herzog, T. J., Barrett, C., and A Bois, du, “Quality of life in patients with advanced epithelial ovarian cancer (EOC) randomized to maintenance pazopanib or placebo after first-line chemotherapy in the AGO-OVAR 16 trial.”, Ann Oncol, vol. 29, no. 3, pp. 737-743, 2018.
D. K. Gaffney, Hashibe, M., Kepka, D., Maurer, K. A., and Werner, T. L., “Too many women are dying from cervix cancer: Problems and solutions.”, Gynecol Oncol, 2018.
2017
W. Small, Bacon, M., Bajaj, A., Chuang, L. T., Fisher, B. J., Harkenrider, M. M., Jhingran, A., Kitchener, H. C., Mileshkin, L. R., Viswanathan, A., and Gaffney, D. K., “Cervical cancer: A global health crisis.”, Cancer, vol. 123, no. 13, pp. 2404-2412, 2017.
J. McGee, Bookman, M., Harter, P., Marth, C., McNeish, I., Moore, K. N., Poveda, A., Hilpert, F., Hasegawa, K., Bacon, M., Gatsonis, C., Brand, A., Kridelka, F., Berek, J., Ottevanger, N., Levy, T., Silverberg, S., Kim, B. - G., Hirte, H., Okamoto, A., Stuart, G., and Ochiai, K., “Fifth Ovarian Cancer Consensus Conference: individualized therapy and patient factors”, Annals of Oncology, vol. 28, no. 4, pp. 702 - 710, 2017.
F. Joly, Hilpert, F., Okamoto, A., Stuart, G., Ochiai, K., and Friedlander, M., “Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer”, European Journal of Cancer, vol. 78, pp. 133 - 138, 2017.
A. Karam, Ledermann, J. A., Kim, J. - W., Sehouli, J., Lu, K., Gourley, C., Katsumata, N., Burger, R. A., Nam, B. - H., Bacon, M., Ng, C., Pfisterer, J., Bekkers, R. L. M., A. Herráez, C., Redondo, A., Fujiwara, H., Gleeson, N., Rosengarten, O., Scambia, G., Zhu, J., Okamoto, A., Stuart, G., and Ochiai, K., “Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions”, Annals of Oncology, vol. 28, no. 4, pp. 711 - 717, 2017.
M. K. Wilson, Pujade-Lauraine, E., Aoki, D., Mirza, M. R., Lorusso, D., Oza, A. M., A. Bois, du, Vergote, I., Reuss, A., Bacon, M., Friedlander, M., Gallardo-Rincon, D., Joly, F., Chang, S. - J., Ferrero, A. M., Edmondson, R. J., Wimberger, P., Maenpaa, J., Gaffney, D., Zang, R., Okamoto, A., Stuart, G., and Ochiai, K., “Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease”, Annals of Oncology, vol. 28, no. 4, pp. 727 - 732, 2017.
A. F. Leary, Quinn, M., Fujiwara, K., Coleman, R. L., Kohn, E., Sugiyama, T., Glasspool, R., Ray-Coquard, I., Colombo, N., Bacon, M., Zeimet, A., Westermann, A., Gomez-Garcia, E., Provencher, D., Welch, S., Small, W., Millan, D., Okamoto, A., Stuart, G., and Ochiai, K., “Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup (GCIG): clinical trial design for rare ovarian tumours”, Annals of Oncology, vol. 28, no. 4, pp. 718 - 726, 2017.
M. A. Bookman, Okamoto, A., Stuart, G. C. E., Yanaihara, N., Aoki, D., Bacon, M., Fujiwara, K., González-Martín, A., Harter, P., Kim, J. W., Ledermann, J. A., Pujade-Lauraine, E., Quinn, M., and Ochiai, K., “Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference.”, Ann Oncol, vol. 28, no. suppl_8, pp. viii30-viii35, 2017.
M. A. Bookman, Okamoto, A., Stuart, G., Yanaihara, N., Aoki, D., Bacon, M., Fujiwara, K., González-Martín, A., Harter, P., Kim, J. W., Ledermann, J., Pujade-Lauraine, E., Quinn, M., and Ochiai, K., “Harmonising clinical trials within the Gynecologic Cancer InterGroup: consensus and unmet needs from the Fifth Ovarian Cancer Consensus Conference”, Annals of Oncology, vol. 28, pp. viii30 - viii35, 2017.

Pages